Eversio Wellness Announces Inclusion on Health Canada’s List of Licensed Psilocybin Producers
SURREY, BC / ACCESSWIRE / January 31, 2022 / Eversio Wellness Ltd. (“Eversio” or the “Company”), a Canadian mushroom wellness company, is pleased to announce that it has been included on Health Canada’s list of federally licenced psilocybin producers.
Health Canada’s list of approved psilocybin producers provides qualified healthcare practitioners access to psilocybin as an alternative treatment for patients under its Special Access Program (SAP), and researchers with a source of natural psilocybin for the purpose of conducting clinical trials in Canada. The SAP is a federal program that allows qualified healthcare practitioners to request for their patients, specific non-marketed medications that demonstrate clinical evidence of safety and efficacy.
This list is available upon request to qualified healthcare practitioners interested in accessing psilocybin through the SAP or for scientific research.
On January 5, 2022, Health Canada enacted formal amendments to the SAP with the intent to increase access to psychedelics-based therapies that were previously available only through clinical trials.
“Eversio means change, and this is the change we’ve been patiently waiting for. As a company with a Controlled Substance Dealer’s Licence and a mission to change lives through fungi, this amendment brings us one step closer to providing those with physical, emotional, and mental health issues access to legal natural psilocybin through consultation with their physician,” said Craig Garden, Chief Executive Officer of Eversio Wellness. “We are honoured to be the first supplier shown on Health Canada’s list.”
Psilocybin producing mushrooms, commonly known as magic mushrooms, contain the naturally occurring psychoactive compound, psilocybin, and have been involved in numerous clinical trials and studies investigating their potential benefits for treating depression, post-traumatic stress disorder, addiction and withdrawal, autoimmune diseases and other brain health conditions.
For more information about the SAP and Eversio Wellness, please email hello@eversiowellness.com.
ABOUT EVERSIO WELLNESS LTD.
Eversio is a Canadian mushroom wellness company providing high-potency, organic functional mushroom extract products and developing novel formulations with psilocybin. Eversio offers functional mushroom extract capsules and blends made from only the whole fruiting body of the functional mushroom life cycle with a therapeutic dose of beneficial compounds in each serving. No mycelium, fillers, or grain. For more information on Eversio, visit: https://www.eversiowellness.com/.
CONTACT:
Craig Garden, Co-Founder and CEO, Eversio Wellness Ltd.
craigg@eversiowellness.com
778.608.4200
FORWARD-LOOKING INFORMATION
This news release contains forward-looking information within the meaning of Canadian securities laws regarding the Company and its business, which relate to future events or future performance and reflect management’s current expectations and assumptions. Often but not always, forward-looking information can be identified by the use of words such as “expect”, “intends”, “anticipated”, “believes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would” or “will” be taken, occur or be achieved. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Readers are cautioned that these forward-looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected including, without limitation, risks regarding the Company’s ability to bring its products to commercial production, natural health products and digital health industries, and the risks presented by the highly regulated and competitive market concerning the development, production, sale and use of the Company’s products. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. These forward-looking statements are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required under applicable securities legislation.
SOURCE: Eversio Wellness Ltd.
View source version on accesswire.com:
https://www.accesswire.com/686490/Eversio-Wellness-Announces-Inclusion-on-Health-Canadas-List-of-Licensed-Psilocybin-Producers
